Leidos Donates $2.5 Million to the Children's Inn at NIH To Expand Support for Pediatric Research
Leidos (NYSE:LDOS) announced a $2.5 million donation to The Children's Inn at the National Institutes of Health to support renovations and expansions. The contribution will help increase The Inn's capacity to serve young patients and families participating in pediatric research. The donation is part of The Children's Inn's $50 million 'Building Extraordinary' capital campaign, which aims to enhance facilities and services. Upon completion in 2027, the expansion will increase capacity by 25%, allowing accommodation for up to 3,000 patients annually. In recognition of this gift, The Inn's new porte-cochere will bear the Leidos name.
Leidos (NYSE:LDOS) ha annunciato una a The Children's Inn presso i National Institutes of Health per supportare ristrutturazioni ed espansioni. Il contributo aiuterà a incrementare la capacità dell'Inn per assistere i giovani pazienti e le famiglie che partecipano alla ricerca pediatrica. La donazione fa parte della campagna di raccolta fondi ‘Building Extraordinary’ dell'Inn, che mira a migliorare le strutture e i servizi. Al termine dei lavori, previsto per il 2027, l'espansione aumenterà la capacità del 25%, consentendo l'accoglienza di fino a 3.000 pazienti all'anno. In riconoscimento di questo dono, il nuovo porte-cochère dell'Inn porterà il nome di Leidos.
Leidos (NYSE:LDOS) anunció una a The Children's Inn en los Institutos Nacionales de Salud para apoyar las renovaciones y expansiones. La contribución ayudará a aumentar la capacidad del Inn para atender a los jóvenes pacientes y a las familias que participan en la investigación pediátrica. La donación forma parte de la campaña de capital de 'Building Extraordinary' del Inn, que tiene como objetivo mejorar las instalaciones y los servicios. Una vez completada en 2027, la expansión aumentará la capacidad en 25%, permitiendo alojar hasta 3,000 pacientes anualmente. En reconocimiento a este regalo, el nuevo porte-cochère del Inn llevará el nombre de Leidos.
Leidos (NYSE:LDOS)는 250만 달러의 기부를 미국 국립 보건원(The Children's Inn)에서 리노베이션 및 확장을 지원하기 위해 발표했습니다. 이 기부는 소아 연구에 참여하는 젊은 환자와 가족들을 지원하기 위한 시설의 수용 능력을 늘리는 데 도움을 줄 것입니다. 이 기부는 5000만 달러 규모의 'Building Extraordinary' 자본 모금 캠페인의 일환으로, 시설과 서비스 개선을 목표로 하고 있습니다. 2027년 완료되면 규모가 25% 증가하여 연간 3000명의 환자를 수용할 수 있게 됩니다. 이 기부를 기념하기 위해 Inn의 새로운 포르테 코쉐에는 Leidos의 이름이 새겨질 것입니다.
Leidos (NYSE:LDOS) a annoncé un don de 2,5 millions de dollars à The Children's Inn des National Institutes of Health pour soutenir les rénovations et les extensions. Cette contribution aidera à augmenter la capacité de l'Inn à servir les jeunes patients et les familles participant à la recherche pédiatrique. Le don fait partie de la campagne de collecte de fonds 'Building Extraordinary' de l'Inn, qui vise à améliorer les installations et les services. À l'achèvement prévu en 2027, l'extension augmentera la capacité de 25%, permettant d'accueillir jusqu'à 3 000 patients par an. En reconnaissance de ce don, le nouveau porte-cochère de l'Inn portera le nom de Leidos.
Leidos (NYSE:LDOS) hat eine Spende von 2,5 Millionen Dollar an The Children's Inn der National Institutes of Health angekündigt, um Renovierungen und Erweiterungen zu unterstützen. Der Beitrag wird helfen, die Kapazität des Inn zur Betreuung junger Patienten und Familien, die an der pädiatrischen Forschung teilnehmen, zu erhöhen. Die Spende ist Teil der ‘Building Extraordinary’ Kapital-Kampagne des Inn, die darauf abzielt, die Einrichtungen und Dienstleistungen zu verbessern. Mit der Fertigstellung im Jahr 2027 wird die Kapazität um 25% steigen und die Unterbringung von bis zu 3.000 Patienten jährlich ermöglichen. Zur Anerkennung dieser Gabe wird der neue Porte-cochère des Inn den Namen Leidos tragen.
- None.
- None.
Insights
This
The naming rights for the porte-cochere provides lasting brand visibility at a prominent NIH-adjacent facility, while the focus on pediatric research aligns with Leidos' health solutions portfolio. This builds on their existing healthcare credentials and could strengthen their competitive position for future NIH and HHS contracts. The donation's timing and scale suggest a well-planned approach to maintaining strong government relationships while generating positive PR value.
The strategic value of this donation extends beyond philanthropy - it positions Leidos advantageously within the NIH ecosystem, where the company already holds significant contracts. The expansion project's completion target of 2027 coincides with increasing federal investment in rare disease research and precision medicine initiatives. By supporting The Children's Inn's infrastructure expansion, Leidos gains early insights into emerging pediatric research trends and maintains proximity to key NIH decision-makers.
For investors, this represents a calculated investment in relationship capital within the healthcare sector, particularly valuable as Leidos competes for federal health IT and research support contracts. The donation's scale relative to Leidos'
RESTON, VA / ACCESSWIRE / December 18, 2024 / Leidos (NYSE:LDOS) announced a
"For more than two decades, Leidos has stood alongside The Children's Inn, championing its mission to create a place like home for children and families fighting rare and complex diseases," said Leidos CEO Tom Bell. "This donation reflects our deep commitment to advancing medical research and supporting the courageous families who inspire us every day."
The gift supports The Children's Inn's
"As a company dedicated to delivering innovative health solutions, we are honored to deepen our partnership with The Children's Inn," said Liz Porter, Leidos Health & Civil Sector president. "This transformative project strengthens essential support for families while driving the advancement of life-changing medical discoveries."
The donation underscores Leidos' mission-driven focus on advancing health and clinical research in collaboration with the U.S. Department of Health and Human Services. It also highlights Leidos' long-standing partnership with The Children's Inn, reflecting decades of support that includes volunteer work, board leadership, financial sponsorships, and program engagement.
"Leidos has been a fundamental pillar of support for The Children's Inn for more than 20 years, and its ongoing support has made an indelible impact on the lives of countless families," said The Inn's CEO Jennie Lucca. "This donation will help bring our vision for The Inn of Tomorrow to life, providing an even more welcoming and supportive environment for children and families who come to the NIH for life-saving treatments. Leidos' generosity is a testament to its belief in the power of innovation and compassion to change lives."
This donation builds on Leidos' recent contributions to Drake State Community & Technical College and Hampton University, further demonstrating the company's broader commitment to improving lives in the communities it serves.
About Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world's most vexing challenges in national security and health. The company's global workforce of 48,000 collaborates to create smarter technology solutions for customers in heavily regulated industries. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately
About The Children's Inn
The Children's Inn at NIH is a private, nonprofit "Place Like Home" for children and their families participating in pediatric research at the National Institutes of Health Clinical Center, the world's premier biomedical research hospital. The Inn reduces the burden of illness through therapeutic, educational, and recreational programming at no cost to families. Since opening in 1990, more than 16,000 families from around the world and all 50 states have made The Inn their home during clinical trials. As a partner in discovery and care with the NIH, The Inn strives for the day when no family endures the heartbreak of a seriously ill child.
The NIH Clinical Center is at the forefront of a new era of promising pediatric research. As the world leader in rare disease research, the NIH is positioned to make significant breakthroughs in treating rare inherited diseases, most of which continue to lack a safe, effective treatment. The Clinical Center has about 1,500 active protocols, one-third of which include children. Propelled by advances in gene therapy and cellular engineering, NIH researchers anticipate advanced treatments and even cures for some rare genetic diseases on the horizon.
Milad Bahrami (center), Leidos senior vice president of health solutions, presents a donation check to Jennie Lucca (left), CEO, The Children's Inn; and Brian Kelly (right), board chair, The Children's Inn, editorial director and executive vice president, U.S. News and World Report. (Photo: The Children's Inn at NIH)
View additional multimedia and more ESG storytelling from Leidos on 3blmedia.com.
Contact Info:
Spokesperson: Leidos
Website: https://www.3blmedia.com/profiles/leidos
Email: info@3blmedia.com
SOURCE: Leidos
View the original press release on accesswire.com
FAQ
How much did Leidos (LDOS) donate to The Children's Inn at NIH in December 2023?
What is the total value of The Children's Inn's 'Building Extraordinary' capital campaign that LDOS is supporting?
When will The Children's Inn expansion project supported by LDOS be completed?
What capacity increase will The Children's Inn achieve through the expansion project supported by LDOS?
How long has Leidos (LDOS) been supporting The Children's Inn at NIH?
